Increased frequencies of Th17 cells in drug eruptions

Journal of Dermatological Science

Volumn 73, Issue 1, 2014, Pages 85-88

  Fujiyama, Toshiharu ^a   Kawakami, Chika ^b   Sugita, Kazunari ^b   Kubo Kabashima, Rieko ^b   Sawada, Yu ^b   Hino, Ryosuke ^b   Nakamura, Motonobu ^b   Shimauchi, Takatoshi ^a   Ito, Taisuke ^a   Kabashima, Kenji ^c   Hashizume, Hideo ^d   Tokura, Yoshiki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Shimada Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CD3 ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; THYMIDINE;

CD4 CD8 RATIO; CELL INFILTRATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DRESS SYNDROME; DRUG ERUPTION; ENZYME SYNTHESIS; ERYTHEMA MULTIFORME; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; LYMPHOCYTE TRANSFORMATION TEST; MACULOPAPULAR RASH; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; STEVENS JOHNSON SYNDROME; TH17 CELL; TH2 CELL; TOXIC EPIDERMAL NECROLYSIS;

BIOPSY; CELLS, CULTURED; CHEMOTAXIS, LEUKOCYTE; CYTOKINES; DRUG ERUPTIONS; HUMANS; LYMPHOCYTE COUNT; SKIN; TH17 CELLS; TIME FACTORS;

EID: 84890118905     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.08.008     Document Type: Letter

References (10)

1. Hashizume H., Takigawa M., Tokura Y. Characterization of drug-specific T cells in phenobarbital-induced eruption. J Immunol 2002, 168:5359-5368.
2. Abe R. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases. J Dermatol Sci 2008, 52:151-159.
3. Shiohara T., Kano Y., Takahashi R., Ishida T., Mizukawa Y. Drug-induced hypersensitivity syndrome: recent advances in the diagnosis, pathogenesis and management. Chem Immunol Allergy 2012, 97:122-138.
4. Nishio D., Izu K., Kabashima K., Tokura Y. T cell populations propagating in the peripheral blood of patients with drug eruptions. J Dermatol Sci 2007, 48:25-33.
5. Koga C., Kabashima K., Shiraishi N., Kobayashi M., Tokura Y. Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 2008, 128:2625-2630.
6. Kabashima R., Sugita K., Sawada Y., Hino R., Nakamura M., Tokura Y. Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. J Eur Acad Dermatol Venereol 2011, 25:485-488.
7. Auquier-Dunant A., Mockenhaupt M., Naldi L., Correia O., Schroder W., Roujeau J.C. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol 2002, 138:1019-1024.
8. Hashizume H., Hansen A., Poulsen L.K., Thomsen A.R., Takigawa M., Thestrup-Pedersen K. In vitro propagation and dynamics of T cells from skin biopsies by methods using interleukins-2 and -4 or anti-CD3/CD28 antibody-coated microbeads. Acta Derm Venereol 2010, 90:468-473.
9. Tearaki Y., Kawabe M., Izaki S. Possible role of TH17 cells in the pathogenesis of Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 2013, 131:907-909.
10. Sugita K., Tohyama M., Watanabe H., Otsuka A., Nakajima S., Iijima M., et al. Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome. J Allergy Clin Immunol 2010, 126:408-410.